Limitations, agreements, and source contact

An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib) · Source last updated 2012-01-30

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

point Of Contact

email

HVDVELDE@ITS.JNJ.COM

organization

Johnson & Johnson Pharmaceutical Research & Development

title

Helgi van de Velde, MD, PhD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice